Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5323324 | 0.81 | — | — | |
| SCHEMBL990066 | 0.81 | — | — | |
| SCHEMBL9868926 | 0.79 | CHRM2 (0.37) | CHRM2CHRM4CHRM5CHRM3 | |
| SCHEMBL17264874 | 0.79 | CHRM2 (0.37) | CHRM2CHRM4CHRM5CHRM3 | |
| SCHEMBL17264875 | 0.79 | CHRM2 (0.37) | CHRM2CHRM4CHRM5CHRM3 | |
| SCHEMBL8281881 | 0.77 | CHRM2 (0.35) | CHRM2CHRM4CHRM5CHRM3 | |
| SCHEMBL8281878 | 0.77 | CHRM2 (0.35) | CHRM2CHRM4CHRM5CHRM3 | |
| SCHEMBL8281880 | 0.77 | CHRM2 (0.35) | CHRM2CHRM4CHRM5CHRM3 | |
| SCHEMBL30896282 | 0.75 | CHRM2 (0.34) | CHRM2CHRM4CHRM5CHRM3 | |
| SCHEMBL27431188 | 0.75 | CHRM2 (0.34) | CHRM2CHRM4CHRM5CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210188856-A1 | CRYSTAL FORM OF HYDROCHLORIDE OF PYRAZOLOHETEROARYL DERIVATIVE AND PREPARATION METHOD | SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD (CN) | 2021-06-24 | — | — | US | claimed |
| EP-3808745-A1 | CRYSTAL FORM OF HYDROCHLORIDE OF PYRAZOLOHETEROARYL DERIVATIVE AND PREPARATION METHOD | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2021-04-21 | — | — | EP | claimed |
| WO-2015058141-A1 | NUCLEOBASE-CONTAINING MONOMERS AND COPOLYMERS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2015-04-23 | — | — | WO | claimed |
| CN-111819178-B | Crystal form of pyrazolo heteroaryl derivative hydrochloride and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20210188856-A1 | CRYSTAL FORM OF HYDROCHLORIDE OF PYRAZOLOHETEROARYL DERIVATIVE AND PREPARATION METHOD | SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD (CN) | 2021-06-24 | — | — | US | disclosed |
| EP-3808745-A1 | CRYSTAL FORM OF HYDROCHLORIDE OF PYRAZOLOHETEROARYL DERIVATIVE AND PREPARATION METHOD | Jiangsu Hengrui Medicine Co., Ltd. (CN) | 2021-04-21 | — | — | EP | disclosed |
| CN-111819178-A | Crystal form of pyrazolo heteroaryl derivative hydrochloride and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2020-10-23 | — | — | CN | disclosed |
| EP-0733038-A1 | BLEACH ACTIVATOR PREPARATION | SOLVAY INTEROX LIMITED (GB) | 1996-09-25 | — | — | EP | disclosed |
| WO-1995015942-A1 | BLEACH ACTIVATOR PREPARATION | SOLVAY INTEROX LIMITED (GB) | 1995-06-15 | — | — | WO | disclosed |
| US-4006141-A | MICROBIOCIDE | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1977-02-01 | — | — | US | disclosed |
| US-3989832-A | Combating bacteria with nitroimidazolyl-triazolo-pyridiazine compounds | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1976-11-02 | — | — | US | disclosed |
| US-3962242-A | BACTERIOSTATS, URINARY TRACT INFECTIONS | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210188856-A1 | CRYSTAL FORM OF HYDROCHLORIDE OF PYRAZOLOHETEROARYL DERIVATIVE AND PREPARATION METHOD | CYP2F1, CYP7A1, CYP11B2 | CHRM2 2074/4885CHRM4 2774/4885CHRM5 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.